Patient Care Outreach, Navigation, Technology and Support (COUNTS) 2.0
The Patient Care Outreach, Navigation, Technology and Support 2.0 Study
This project will test a multilingual virtual patient navigation portal to help English-, Chinese-, and Spanish-speaking adults with breast cancer or cardiovascular disease in underserved communities.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 260 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 2 sites (San Francisco, California and 1 other locations) |
| Trial ID | NCT06648278 on ClinicalTrials.gov |
What this trial studies
COUNTS 2.0 builds on an existing patient navigation program by expanding an online portal and materials into Chinese and Spanish and testing usability in underserved communities. The team will recruit participants through UCSF clinics, registries, Zuckerberg San Francisco General, and community partners, using focus groups with patients, navigators, caregivers, and social workers to refine culturally specific content. Enrolled participants and family members will use the web portal and receive virtual navigation, complete quality-of-life assessments and surveys, and receive outreach messages over a six-to-seven month follow-up. The study is primarily a feasibility and implementation effort to determine reach, acceptability, and practical barriers to wider rollout.
Who should consider this trial
Good fit: Ideal candidates are adults (18+) diagnosed with any stage breast cancer or with cardiovascular disease who speak English, Mandarin/Cantonese, or Spanish, are connected to UCSF/ZSFG or partner outreach channels, and have access to a phone that can receive text messages.
Not a fit: Patients without reliable phone or internet access, those who cannot provide informed consent for medical or psychological reasons, or those who require only in-person navigation may not benefit from this virtual program.
Why it matters
Potential benefit: If successful, this could expand access to culturally and linguistically appropriate navigation services for underserved patients, improving care coordination and access to resources.
How similar studies have performed: Earlier navigation programs, including the original Patient COUNTS, have shown promise in supporting underserved patients, but fully virtual, multilingual portal implementations remain less tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: For Focus groups: * Breast cancer patients: Diagnosed with breast cancer, ages 18 or older, speaks English, Mandarin/Cantonese, or Spanish * Navigators: any patient navigator who has provided care to underserved populations diagnosed with cancer For Portal Implementation phase: * Ages 18 or older * Speaks English, Mandarin/Cantonese, Spanish, * Has any stage breast cancer * Has access to a phone that is able to receive text messages, is willing to stay in the study for six-seven months. Family User experience survey: * Family member or friend who may have assisted breast cancer participant with registration, accessing or otherwise assisting breast cancer family member or friend participant with the online portal. Exclusion Criteria: * Any medical or psychological conditions precluding informed consent
Where this trial is running
San Francisco, California and 1 other locations
- Zuckerberg San Francisco General Hospital — San Francisco, California, United States (Recruiting)
- University of California, San Francisco — San Francisco, California, United States (Recruiting)
Study contacts
- Principal investigator: Scarlett L Gomez, PhD — University of California, San Francisco
- Study coordinator: Laura Allen
- Email: Laura.Allen@ucsf.edu
- Phone: 415-818-7143
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.